' x='0' y='0' width='795' height='447'%3E%3C/rect%3E%3Ctext id='Loading-Preview' font-family='AvenirNext-Bold, Avenir Next' font-size='42' font-weight='bold' fill='%23FFFFFF'%3E%3Ctspan x='228.715' y='211'%3ELoading Preview%3C/tspan%3E%3C/text%3E%3C/g%3E%3C/g%3E%3C/svg%3E)
Description | RYSTIGGO is the first FDA-approved treatment for both anti-AChR and anti-MuSK antibody-positive adults with generalized myasthenia gravis (gMG). |
h1 tags | REACH HIGHER with RYSTIGGO* |
h2 tags | for adults with GENERALIZED MYASTHENIA GRAVIS (gMG) who are anti-AChR or anti-MuSK antibody positive Significant improvements in activities of daily living Targeted gMG treatment Here for you throughout your treatment You are now leaving RYSTIGGO.com |
Site Speed | 0.23126721382141 |
Alexa Rank: |
0 |
Site's Traffic |
|
| Host | Type | Class | TTL | Target |
| rystiggo.com | HINFO | IN | 300 |